An analysis of 115 plant-based milk sold in Australia showed that the category is lacking in several micronutrients, including vitamin A, B12, calcium, and protein when compared to cow’s milk.
In this round-up of new scientific developments, we look at how orange juice could be a non-dairy carrier for probiotics, opportunities for active nutrition NPD and more.
Japan’s Taisho Pharmaceutical Holdings is stepping up product development in its nutrition business, as its prescription pharmaceutical struggles to secure significant growth opportunities.
There is huge scope in tailoring active and sports nutrition products toward the general population, especially if the can also offer immunity benefits, an expert panel has underlined.
There is currently only low-certainty evidence to show that consuming galactagogues can increase breast milk production in nursing mothers, with a group of Malaysian researchers who conducted a recent Cochrane systematic review recommending further studies...
India’s raw turmeric price this year is about 10% lower than last year partly because COVID-19 lockdowns and market closures have led to a surplus, said a major merchant association in India.
In this round-up, we zoom in on new developments in big brands, including how Amway India aims to achieve 90% of its pre-lockdown business by next month, Swisse adopting a ‘digital’ first strategy in India, and Ajinomoto’s debut in the VMS space.
Amway India’s CEO Anshu Budhraja says the firm is hopeful of achieving 80% to 90% of its pre-lockdown business by next month, as the country’s economy seeks to bounce back from COVID-19 pandemic.
The future of botanicals and immunity research should include studies with adequate sample size, long-term safety studies and include more pharmacokinetic data, an expert panel has concluded.
Health and wellness brands Swisse and Power Gummies say they are taking a “digital-first” strategy in India as uptake of online retail speeds up in the country.
The Healthy Ageing APAC Summit has been rescheduled to July 2021 in light of the ongoing uncertainty caused by the COVID-19 pandemic, but the topic will still take centre stage this year as part of a new interactive broadcast series - Growth Asia 2020...
The New Zealand natural health products industry’s combined revenue last year was NZD$2.3bn (US$1.4bn), up 64% from five years ago, but the potential of even greater growth has been hampered by regulatory restrictions and low working capital.
